Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Protective Antigen (PA) of Bacilus anthracis (MMS_105) (ID# 7646)
![](https://www.aptagen.com/wp-content/uploads/peptide.png)
Peptide
Protective Antigen (PA) of Bacilus anthracis
Cells
19.1 nM (reported value)
Binding Buffer: PBSB (PBS buffer plus 0.5% BSA), 4°C
N/A°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
71.6% Binding to 150 nM PA. The clone with the highest binding percentage was MMS_128 at 89.8% (Kd=54.9 nM).
NH2-AsnTrpLeuCysPheThrCysGlyMetAspPheIleAspProAsp-COOH
![](/wp-content/uploads/apta-sequence-abbr.png)
15
1967.27
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Kogot et al. "Screening of Peptide Libraries against Protective Antigen of Bacillus anthracis in a Disposable Microfluidic Cartridge." PloS One, 6(11): e26925. doi:10.1371/journal.pone.0026925
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.